Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.66%102.53B | 3.56%105.67B | 2.33%92.97B | 3.31%402.77B | 2.84%106.67B | 2.24%103.21B | 3.94%102.04B | 4.39%90.85B | 6.45%389.87B | 5.16%103.73B |
Cost of revenue | -4.31%55.23B | 3.86%57.57B | -1.69%50.73B | 3.21%222.17B | 1.11%57.42B | 2.96%57.72B | 1.36%55.43B | 8.11%51.6B | 15.03%215.26B | 7.62%56.79B |
Gross profit | 3.96%47.3B | 3.19%48.1B | 7.61%42.23B | 3.43%180.6B | 4.92%49.25B | 1.35%45.49B | 7.20%46.61B | -0.13%39.25B | -2.51%174.61B | 2.32%46.94B |
Operating expense | 11.01%43.54B | -7.24%39.63B | 1.23%37.34B | 9.83%160.09B | 1.89%41.26B | 6.71%39.23B | 7.62%42.73B | 28.03%36.88B | -1.46%145.76B | 0.79%40.49B |
Selling and administrative expenses | -2.61%38.23B | -0.49%42.54B | 4.07%38.24B | 6.24%160.47B | 2.74%41.72B | 6.78%39.25B | 7.12%42.75B | 8.78%36.74B | 1.93%151.05B | 0.64%40.61B |
-General and administrative expense | -2.61%38.23B | -0.49%42.54B | 4.07%38.24B | 6.24%160.47B | 2.74%41.72B | 6.78%39.25B | 7.12%42.75B | 8.78%36.74B | 1.93%151.05B | 0.64%40.61B |
Other operating expenses | 2,323.57%6.79B | -59.90%166M | -46.64%246M | 25.53%1.82B | 60.19%668M | -10.83%280M | 132.58%414M | -15.10%461M | 52.47%1.45B | 111.68%417M |
Total other operating income | 379.74%1.47B | 604.13%3.07B | 257.01%1.15B | -67.41%2.2B | 113.18%1.13B | -2.55%306M | 14.44%436M | -94.18%321M | 457.78%6.74B | 43.90%531M |
Operating profit | -40.13%3.75B | 117.98%8.46B | 107.20%4.89B | -28.91%20.51B | 23.96%7.99B | -22.91%6.27B | 2.78%3.88B | -77.48%2.36B | -7.49%28.84B | 13.12%6.45B |
Net non-operating interest income (expenses) | -438.89%-427M | 46.45%536M | 215.65%170M | -57.92%263M | 53.41%-82M | -68.18%126M | -8.50%366M | -3,775.00%-147M | -8.22%625M | -176.19%-176M |
Non-operating interest income | -147.39%-145M | 38.70%724M | 191.30%402M | 37.56%1.11B | 251.09%139M | -28.34%306M | 21.96%522M | 253.85%138M | -1.59%804M | -134.72%-92M |
Non-operating interest expense | 56.67%282M | 20.51%188M | -18.60%232M | 370.95%843M | 163.10%221M | 480.65%180M | 457.14%156M | 714.29%285M | 31.62%179M | 147.06%84M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 24.83%739M | 107.42%699M | 77.00%754M | -11.90%1.61B | -19.81%251M | 36.09%592M | -31.92%337M | -26.68%426M | -18.17%1.82B | -33.97%313M |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -41.81%4.06B | 111.45%9.7B | 120.26%5.82B | -28.50%22.38B | 23.97%8.16B | -22.05%6.98B | -1.84%4.59B | -76.15%2.64B | -8.20%31.29B | 2.75%6.58B |
Income tax | -62.38%705M | 95.60%2.67B | 111.08%1.62B | -30.49%5.69B | 36.59%1.68B | -28.03%1.87B | 4.92%1.37B | -74.83%767M | -5.49%8.18B | -3.98%1.23B |
Net income | -34.25%3.36B | 118.16%7.03B | 124.01%4.2B | -27.79%16.69B | 21.05%6.48B | -19.59%5.11B | -4.45%3.22B | -76.66%1.87B | -9.13%23.11B | 4.47%5.35B |
Net income continuous operations | -34.25%3.36B | 118.16%7.03B | 124.01%4.2B | -27.79%16.69B | 21.05%6.48B | -19.59%5.11B | -4.45%3.22B | -76.66%1.87B | -9.13%23.11B | 4.47%5.35B |
Noncontrolling interests | 12.57%627M | 28.69%646M | 119.26%649M | 76.24%2.06B | 35.25%706M | 83.83%557M | 141.35%502M | 117.65%296M | -29.98%1.17B | 32.15%522M |
Net income attributable to the company | -39.96%2.73B | 134.63%6.38B | 124.84%3.55B | -33.34%14.62B | 19.50%5.77B | -24.79%4.55B | -14.01%2.72B | -80.00%1.58B | -7.66%21.94B | 2.16%4.83B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -39.96%2.73B | 134.63%6.38B | 124.84%3.55B | -33.34%14.62B | 19.50%5.77B | -24.79%4.55B | -14.01%2.72B | -80.00%1.58B | -7.66%21.94B | 2.16%4.83B |
Gross dividend payment | ||||||||||
Basic earnings per share | -38.06%9.91 | 141.53%23.09 | 129.19%12.72 | -33.26%51.42 | 19.41%20.3 | -24.85%16 | -14.11%9.56 | -79.86%5.55 | -5.74%77.04 | 4.49%17 |
Diluted earnings per share | -38.05%9.9 | 141.47%23.06 | 129.24%12.7 | -33.23%51.35 | 19.38%20.27 | -24.84%15.98 | -14.04%9.55 | -79.86%5.54 | -5.74%76.91 | 4.56%16.98 |
Dividend per share | 0 | 0.00%13 | 0 | 4.00%26 | 0.00%13 | 0 | 8.33%13 | 0 | 4.17%25 | 8.33%13 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |